July 8, 2024 – Page 6 – Goldea Capital

Qualifacts and MethodOne by Computalogic Partner to Elevate Controlled Medication Dispensing for Substance Use Disorders

Written by Customer Service on July 8, 2024. Posted in Mergers And Acquisitions.

In partnership with MethodOne by Computalogic “We are excited to partner with Qualifacts to expand access to our comprehensive controlled medication dispensing solution,” said Keith Jones, CEO of MethodOne by Computalogic. “Together, we are empowering SUD treatment providers to deliver high-quality care, improve operational efficiency, and ultimately save lives.” Nashville, Tenn., July 08, 2024 (GLOBE NEWSWIRE) — Qualifacts, the leading provider of end-to-end electronic health record (EHR) software and data solutions for behavioral healthcare organizations, and MethodOne by Computalogic, a comprehensive controlled-medication dispensing solution, announced a strategic partnership to address the escalating opioid epidemic. This collaboration integrates the award-winning EHR platforms from Qualifacts...

Quantum Computing Market Forecast to Grow at 30.7% CAGR from 2024 to 2031 | SkyQuest Technology

Written by Customer Service on July 8, 2024. Posted in Mergers And Acquisitions.

Westford, USA, July 08, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Quantum Computing Market will attain a value of USD 7135 Million by 2031, with a CAGR of 30.7% during the forecast period (2024-2031). Quantum Computing, as it is known today, is the foundation of emerging technologies. Technology has witnessed multiple progresses in the past years, but a few practical barriers are still on the way. The latest success in AI and the conforming boost it gave to the traditional algorithms present an extra obstacle for quantum algorithms. Economies, such as Canada, the United States, and China made some major advances in QC and succeeded in developing quantum computers indigenously. Download a detailed overview:https://www.skyquestt.com/sample-request/quantum-computing-market Browse in-depth TOC on the “Quantum...

SELLAS Receives European Medicines Agency Orphan Drug Designation for SLS009 for the Treatment of Acute Myeloid Leukemia

Written by Customer Service on July 8, 2024. Posted in Public Companies.

NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the European Commission, based on a positive opinion issued by the European Medicines Agency (EMA), has granted Orphan Drug Designation (ODD) for SLS009, a novel, and highly selective CDK9 inhibitor, for the treatment of acute myeloid leukemia (AML). “We are thrilled to receive ODD from the EMA for the treatment of AML. This designation along with the recently announced strong preliminary Phase 2 data and previous FDA ODD designation reinforces our continued progress and commitment to developing SLS009 as a potential treatment for AML,” said Angelos Stergiou,...

Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders

Written by Customer Service on July 8, 2024. Posted in Public Companies.

Extensive Issued and Pending IP Patent Applications Acquired with License Agreement SARASOTA, FL, July 08, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced that it has entered into an exclusive, global license agreement with Columbia University to further develop, manufacture, and commercialize its lead drug candidate, SPC-15, an intranasal treatment for stress-induced affective disorders and PTSD. Silo recently submitted a pre-IND briefing package and meeting request for SPC-15 to the U.S. Food and Drug Administration (FDA) earlier this month. The Company is currently engaged in the final steps required before...

Schouw & Co. share buy-back programme, week 27 2024

Written by Customer Service on July 8, 2024. Posted in Public Companies.

On 4 March 2024, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 13 of 1 March 2024. Under the programme, Schouw & Co. will acquire shares for up to DKK 200 million during the period 4 March 2024 to 31 December 2024. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules). Trading day No. of shares Average price Amount Accumulated until 28/6/2024 140,500 543.47 76,357,900 Monday, 1 July 2024 1,900 550.28 1,045,532 Tuesday, 2 July 2024 1,800 554.46 998,028 Wednesday, 3 July 2024 1,700 559.47 951,099 Thursday, 4 July 2024 1,600 564.84 903,744 Friday,...

Treasure Global Inc Acquires an Innovative Sports Engagement & Gaming Platform

Written by Customer Service on July 8, 2024. Posted in Mergers And Acquisitions.

NEW YORK and KUALA LUMPUR, Malaysia, July 08, 2024 (GLOBE NEWSWIRE) — Treasure Global Inc (NASDAQ: TGL) (“Treasure Global” or the “Company”), a leading technology solutions provider, announces its plan to acquire 100% shareholding of Who Knows Wins Ltd (“Who Knows Wins” or “WKW”), a privately held company based in the United Kingdom. Who Knows Win is an innovative online platform operator of an interactive focused social sports platform. The Company plans to leverage WKW’s innovative platform to penetrate the US market, aligning with major gaming brands to drive growth. The acquisition of WKW aligns with the Company’s strategic vision of leveraging innovative technologies to drive revenue growth, expand in the USA, and further explore opportunities to position WKW as a key player in the sports engagement and gaming industries....

Ormat Technologies, Inc. to Host Conference Call Announcing Second Quarter 2024 Financial Results

Written by Customer Service on July 8, 2024. Posted in Earnings Releases And Operating Results.

RENO, Nev., July 08, 2024 (GLOBE NEWSWIRE) — Ormat Technologies Inc. (NYSE: ORA), a leading renewable energy company, today announced that it plans to publish its second quarter financial results in a press release that will be issued on Tuesday, August 6, 2024, after the market closes. In conjunction with this report, the Company has scheduled a conference call to discuss the results at 9:00 a.m. ET on, August 7, 2024. Participants within the United States and Canada, please dial 1-888-770-2286, approximately 15 minutes prior to the scheduled start of the call. If you are calling outside of the United States and Canada, please dial +1-646-960-0440. The access code for the call is 9122486. Please request the “Ormat Technologies, Inc. call” when prompted by the conference call operator. The conference call will also be accompanied...

RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®

Written by Customer Service on July 8, 2024. Posted in Public Companies.

Publication of data relating to RenovoRx’s targeted therapy platform to treatment of Locally Advanced Pancreatic Cancer (LAPC) is expected to be in the Summer 2024 issue of a prestigious journal LOS ALTOS, Calif., July 08, 2024 (GLOBE NEWSWIRE) — RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced acceptance for publication in an international peer-reviewed journal, The Oncologist. The manuscript is titled, “Treatment of Locally Advanced Pancreatic Cancer (LAPC) Using Localized Trans-Arterial Micro Perfusion (TAMP™) of Gemcitabine: Combined Analysis of RR1 and RR2” and expected in the Summer 2024 issue of The Oncologist The manuscript’s lead author is Hassan Hatoum, MD,...

3D Systems & Precision Resource Announce Strategic Partnership to Advance Metal Additive Manufacturing

Written by Customer Service on July 8, 2024. Posted in Public Companies.

3D Systems’ DMP Flex 350 Dual 3D Systems’ DMP Flex 350 platform is designed for flexible application use from application development to serial production. Collaboration intended to catalyze metal AM applications in high-criticality markets Precision Resource integrating two 3D Systems DMP Flex 350 Dual printers into manufacturing workflow to support efforts DMP Flex 350’s best-in-class environmental control, inert atmosphere ensures exceptionally high-quality parts for precision applications ROCK HILL, S.C. and SHELTON, Conn., July 08, 2024 (GLOBE NEWSWIRE) — Today, 3D Systems (NYSE:DDD), a leading additive manufacturing solutions provider, and Precision Resource, a leader in the production of critical components for the automotive, heavy-duty, aerospace, and medical device industries, announced they have entered...

Conclusion of a notarial deed of pledge by AS Pro Kapital Grupp

Written by Customer Service on July 8, 2024. Posted in Public Companies.

On 22 March 2024, Pro Kapital entered into a share purchase agreement to acquire a 67.5% stake in Preatoni Nuda Proprieta S.R.L. (registered in Milan, Italy). Pursuant to the terms and conditions of the senior secured callable fixed rate bonds 2020/2028 with ISIN SE0013801172, with a total nominal amount outstanding of EUR 19,950,000, issued by Pro Kapital, Pro Kapital is obliged to pledge all of Pro Kapital’s shares of the acquired company in favour of the agent Nordic Trustee & Agency AB and all the bondholders (represented by Nordic Trustee & Agency AB) after the completion of the above mentioned share purchase. Pro Kapital announces that it has entered into the required notarial deed of pledge in Italy on 5 July 2024 in respect of 67.5% of the shares in Preatoni Nuda Proprieta S.R.L. and the Italian notary submitted the relevant...

Day: July 8, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice